Olema Pharmaceuticals, Inc. · NASDAQ:OLMA
Bain Capital Life Sciences Opportunities IV, L.P. reported a 9.99% stake in Olema Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jan 8, 2025 · Filed Jan 13, 2025
Bain Capital Life Sciences Opportunities IV, L.P. reported a 9.99% stake in Olema Pharmaceuticals, Inc., 7,095,780 shares, as a passive investor on Jan 8, 2025. Filed Jan 13, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 7,095,780
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Bain Capital Life Sciences Opportunities IV, L.P. | 9.99% | 7,095,780 |
Source
Related
- Olema Pharmaceuticals, Inc.
- Bain Capital Life Sciences Opportunities IV, L.P.
- Olema Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · May 15, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · Feb 17, 2026
- Schedule 13G/A · Bain Capital Life Sciences Opportunities IV, L.P. · May 15, 2025
- Schedule 13D/A · Bvf Partners L P · Oct 16, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Harmon Cyrus · Jul 27, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026